Nonpeptide inhibitors of measles virus entry

Aiming Sun1, Andrew Prussia, Weiqiang Zhan

  • 1Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, USA.

Insights

New anti-measles compounds offer hope against measles virus (MV) infections. Researchers identified potent fusion inhibitors, like AS-48, demonstrating low-micromolar activity against wild-type MV strains.

Area of Science:

  • Virology
  • Medicinal Chemistry

Background:

  • Measles virus (MV) is a highly contagious pathogen responsible for significant mortality and morbidity globally.
  • Existing vaccines, while effective, do not prevent all infections or complications, highlighting the need for antiviral therapies.

Purpose of the Study:

  • To design, synthesize, and evaluate novel nonpeptidic fusion inhibitors targeting the measles virus.
  • To explore the structure-activity relationships (SAR) of identified inhibitor series to guide further optimization.

Main Methods:

  • Utilized a homology model of the MV fusion protein to identify a putative binding site.
  • Designed and synthesized several series of substituted anilides as potential MV fusion inhibitors.
  • Bioevaluated compounds using assays to determine their inhibitory concentration (IC50) against wild-type MV strains.
  • Applied Molecular Field Topology Analysis (MFTA) for quantitative structure-activity relationship (QSAR) analysis.

Main Results:

  • Identified five substituted anilides exhibiting low-micromolar blockade of MV fusion.
  • One compound, AS-48, demonstrated potent activity with IC50 values ranging from 0.6 to 3.0 microM against various wild-type MV strains.
  • MFTA analysis provided insights into structural features correlating with inhibitory potency, suggesting avenues for improvement.

Conclusions:

  • Substituted anilides represent a promising class of nonpeptidic inhibitors for measles virus fusion.
  • The identified lead compound AS-48 shows significant potential for further development as an anti-measles therapeutic.
  • QSAR analysis can effectively guide the rational design of more potent measles virus entry inhibitors.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...